Scarica l'app Stockscreener
32.99
2.17%
0.70
Dopo l'orario di chiusura:
32.99
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? - Yahoo! Finance Canada
MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed? - Sahm
MBX Biosciences Approves Equity-Based Inducement Grant for New Employee Under Nasdaq Rule - geneonline.com
MBX Biosciences Reports Inducement Grant - National Today
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New MBX business chief gets 130,000 stock options at $32.29 - Stock Titan
Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings - marketbeat.com
MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital - marketbeat.com
MBX Biosciences (NASDAQ:MBX) Shares Up 8.5%What's Next? - marketbeat.com
MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest - marketbeat.com
MBX PE Ratio & Valuation, Is MBX Overvalued - Intellectia AI
221,672 Shares in MBX Biosciences, Inc. $MBX Acquired by Goelzer Investment Management Inc. - marketbeat.com
Assessing MBX Biosciences (MBX) Valuation After CEO Share Purchase And Phase 3 Hypoparathyroidism Plans - Sahm
MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know - Yahoo Finance
Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - msn.com
MBX Biosciences, Inc. (NASDAQ:MBX) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
MBX (NASDAQ: MBX) affiliate files sale notice for 1,061 vested shares - Stock Titan
MBX Biosciences (MBX) Is Down 6.5% After Wider Losses And New Shelf Filings Has The Bull Case Changed? - simplywall.st
Hudson Bay Capital Management LP Purchases New Stake in MBX Biosciences, Inc. $MBX - MarketBeat
Aug Intraday: Can MBX Biosciences Inc keep up with sector leaders2026 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
MBX Biosciences Advances Avail Phase 2 Trial in Hypoparathyroidism: What Investors Should Watch - TipRanks
Top MBX Biosciences (MBX) Competitors 2026 - MarketBeat
MBX Biosciences (MBX) CFO John Smither files initial Form 3 - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
MBX Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
MBX Biosciences Chief Makes Bold Insider Move With Major Stock Buy - TipRanks
Company (NASDAQ: MBX) Form 144 — 10,000-share sale notice via Fidelity - Stock Titan
MBX Biosciences (NASDAQ:MBX) Shares Gap Up After Insider Buying Activity - MarketBeat
A Look At MBX Biosciences (MBX) Valuation After Recent Share Price Pullback - simplywall.st
Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 By Investing.com - Investing.com India
Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 - Investing.com
MBX Biosciences (NASDAQ:MBX) CEO Buys $525,585.00 in Stock - MarketBeat
MBX Biosciences (MBX) CEO adds 18,500 shares via trust purchase - Stock Titan
MBX Phase 3 Plans And New CBO Sharpen Rare Disease Focus - Yahoo Finance
Baker BROS. Advisors LP Takes $4.86 Million Position in MBX Biosciences, Inc. $MBX - MarketBeat
MBX Biosciences completes FDA meeting for Phase 3 trial design - Investing.com Nigeria
Ghisallo Capital Management LLC Takes $669,000 Position in MBX Biosciences, Inc. $MBX - MarketBeat
Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD) - The Globe and Mail
MBX Biosciences Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Citizens reiterates Market Outperform on MBX Biosciences stock - Investing.com Nigeria
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights - Sahm
Cowen Maintains Buy on MBX Biosciences, Inc. Common Stock (MBX) Mar 2026 - Meyka
Decoding MBX Biosciences Inc (MBX): A Strategic SWOT Insight - GuruFocus
Truist reiterates Buy on MBX Biosciences stock, $50 target - Investing.com South Africa
Truist reiterates Buy on MBX Biosciences stock, $50 target By Investing.com - Investing.com India
MBX Biosciences (NASDAQ: MBX) files $250M ATM sales agreement with Jefferies - Stock Titan
Stifel reiterates Buy rating on MBX Biosciences stock, $50 target - Investing.com UK
Stifel reiterates Buy rating on MBX Biosciences stock, $50 target By Investing.com - Investing.com Australia
TD Cowen reiterates Buy on MBX Biosciences stock ahead of Phase III By Investing.com - Investing.com Australia
TD Cowen reiterates Buy on MBX Biosciences stock ahead of Phase III - Investing.com India
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):